Biological activity of Helicobacter pylori components in mammalian cells: Is it independent of proteinase-activated receptors?

Journal of Physiology and Pharmacology

Volumn 63, Issue 6, 2012, Pages 571-576

  Sekiguchi, F ^a   Matsumoto, Y ^a   Maeda, Y ^a   Tsubota Matsunami, M ^a   Nishikawa, H ^a   Kawabata, A ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

A549 cell; HCT 15 cell; Helicobacter pylori; Interleukin 8; Platelet aggregation; Prostaglandin E2; Proteinase activated receptor; RGM1 cell

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; PROSTAGLANDIN E2; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; PROTEINASE INHIBITOR; THROMBIN;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; HEAT TREATMENT; HELICOBACTER PYLORI; MAMMAL CELL; NONHUMAN; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ANIMALS; BACTERIAL PROTEINS; BLOOD PLATELETS; CELL LINE, TUMOR; DINOPROSTONE; HELICOBACTER PYLORI; HOT TEMPERATURE; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; OLIGOPEPTIDES; PLATELET AGGREGATION; PROTEASE INHIBITORS; PROTEIN DENATURATION; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RECEPTORS, PROTEINASE-ACTIVATED; RECEPTORS, THROMBIN; THROMBIN;

EID: 84873422008     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Soh UJ, Dores MR, Chen B, Trejo J. Signal transduction by protease-activated receptors. Br J Pharmacol 2010; 160: 191-203.
2. Steinhoff M, Buddenkotte J, Shpacovitch V, et al. Proteinase-activated receptors: transducers of proteinasemediated signaling in inflammation and immune response. Endocr Rev 2005; 26: 1-43.
3. Sekiguchi F, Kawabata A. Protease-activated receptors (PARs) as therapeutic targets: development of agonists/antagonists and modulation of gastrointestinal functions. Drug Des Rev-Online 2004; 1: 287-296.
4. Sekiguchi F, Takaoka K, Kawabata A. Proteinase-activated receptors in the gastrointestinal system: a functional linkage to prostanoids. Inflammopharmacology 2007; 15: 246-254.
5. Kawabata A, Matsunami M, Sekiguchi F. Gastrointestinal roles for proteinase-activated receptors in health and disease. Br J Pharmacol 2008; 153: S230-S240.
6. Kawabata A. PAR-2: structure, function and relevance to human diseases of the gastric mucosa. Expert Rev Mol Med 2002; 2002: 1-17.
7. Matsumoto Y, Marusawa H, Kinoshita K, et al. Helicobacter pylori infection triggers aberrant expression of activationinduced cytidine deaminase in gastric epithelium. Nat Med 2007; 13: 470-476.
8. Matsuda K, Yamauchi K, Matsumoto T, Sano K, Yamaoka Y, Ota H. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells. Scand J Gastroenterol 2008; 43: 25-33.
9. Backert S, Clyne M. Pathogenesis of Helicobacter pylori infection. Helicobacter 2011; 16(Suppl 1): 19-25.
10. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007; 133: 288-308.
11. Bumann D, Aksu S, Wendland M, et al. Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect Immun 2002; 70: 3396-3403.
12. Beyer BC, Heiss MM, Simon EH, et al. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens. Cancer 2006; 106: 1026-1035.
13. Kajikawa H, Yoshida N, Katada K, et al. Helicobacter pylori activates gastric epithelial cells to produce interleukin-8 via protease-activated receptor 2. Digestion 2007; 76: 248-255.
14. Yoshida N, Yoshikawa T. Basic and translational research on proteinase-activated receptors: implication of proteinase/proteinase-activated receptor in gastrointestinal inflammation. J Pharmacol Sci 2008; 108: 415-421.
15. Wee JL, Chionh YT, Ng GZ, et al. Protease-activated receptor-1 down-regulates the murine inflammatory and humoral response to Helicobacter pylori. Gastroenterology 2010; 138: 573-582.
16. Lim JW, Kim H. Role of protease-activated receptor-2 on cell death and DNA fragmentation in Helicobacter pyloriinfected gastric epithelial cells. J Transl Med 2010; 8: 85.
17. 2 formation in human lung epithelial cells. J Pharmacol Exp Ther 2005; 315: 576-589.
18. 2 formation caused by proteinase-activated receptor-1 activation in rat gastric mucosal epithelial cells. Biochem Pharmacol 2007; 73: 103-114.
19. Tanaka Y, Sekiguchi F, Hong H, Kawabata A. PAR2 triggers IL-8 release via MEK/ERK and PI3-kinase/Akt pathways in GI epithelial cells. Biochem Biophys Res Commun 2008; 377: 622-626.
20. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404: 609-613.
21. Hollenberg MD, Saifeddine M. Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides. Can J Physiol Pharmacol 2001; 79: 439-442.
22. Hata T, Kawabata A, Itoh E. Platelet hypoaggregability in rats exposed to SART stress (repeated cold stress). Thromb Res 1992; 65: 617-629.
23. Kawabata A, Hata T. Characterization of platelet hypofunctions in rats under SART stress (repeated cold stress). Thromb Res 1993; 69: 197-207.
24. 2 release in rat gastric epithelial RGM1 cells. J Cell Biochem 2011; 112: 909-915.
25. Moriyuki K, Nagataki M, Sekiguchi F, Nishikawa H, Kawabata A. Signal transduction for formation/release of interleukin-8 caused by a PAR2-activating peptide in human lung epithelial cells. Regul Pept 2008; 145: 42-48.
26. 2-COX-1-microsomal PGE synthase-1 cascade in human lung epithelial cells. Cell Biochem Funct 2008; 26: 279-282.
27. Yokota S, Ohnishi T, Muroi M, Tanamoto K, Fujii N, Amano K. Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol Med Microbiol 2007; 51: 140-148.
28. Smith SM, Moran AP, Duggan SP, et al. Tribbles 3: a novel regulator of TLR2-mediated signaling in response to Helicobacter pylori lipopolysaccharide. J Immunol 2011; 186: 2462-2471.
29. Grebowska A, Moran AP, Bielanski W, et al. Helicobacter pylori lipopolysaccharide activity in human peripheral blood mononuclear leukocyte cultures. J Physiol Pharmacol 2010; 61: 437-442.
30. 2 suppresses RANTES expression by inhibiting NADPH oxidase activation in Helicobacter pylori-infected gastric epithelial cells. J Physiol Pharmacol 2011; 62: 167-174.
31. Miyoshi T, Yamashita K, Arai T, Yamamoto K, Mizugishi K, Uchiyama T. The role of endothelial interleukin-8/NADPH oxidase 1 axis in sepsis. Immunology 2010; 131: 331-339.
32. Byrne MF, Kerrigan SW, Corcoran PA, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003; 124: 1846-1854.